Amyloid blood biomarker detects Alzheimer's disease

Amyloid blood biomarker detects Alzheimer's disease

Abstract Alzheimer's disease (AD) is currently incurable, but there is general agreement that a minimally invasive blood biomarker for screening in preclinical stages would be crucial for future therapy. Diagnostic tools for detection of AD are either invasive like cerebrospinal fluid (CSF) bio...

Full description

Bibliographic Details
Main Authors: Andreas Nabers, Laura Perna, Julia Lange, Ute Mons, Jonas Schartner, Jörn Güldenhaupt, Kai‐Uwe Saum, Shorena Janelidze, Bernd Holleczek, Dan Rujescu, Oskar Hansson, Klaus Gerwert, Hermann Brenner
Format: Article
Language:English
Published: Wiley 2018-05-01
Series:EMBO Molecular Medicine
Subjects:
Alzheimer's disease diagnosis
amyloid‐β in blood plasma
BioFINDER
ESTHER
immuno‐infrared‐sensor
Online Access:https://doi.org/10.15252/emmm.201708763

Internet

https://doi.org/10.15252/emmm.201708763

Similar Items